Managing malnutrition UK

Let’s Simplify The Process Of Managing Malnutrition

We understand that the management of malnutrition can be seen as complex, and with complexity can come wastage.

With over 100 products to choose from,¹ the cost and prescribing of oral nutritional supplements (ONS) can be difficult to manage. However, the risks of not managing malnutrition properly are real, with physical wastage for the patient, and economic wastage for the NHS.

What’s The Impact Of Malnutrition On Your Resources?

Patients who are malnourished are twice as likely to visit their GP, more likely to be admitted into hospital and stay in hospital longer than well-nourished patients.²

Malnutrition is a public health problem, estimated to cost at least £19.6 billion in England (£23.5 billion in the UK), which is about 15% of the total expenditure on health and social care.³

With 10% of over 65s with, or at risk of, malnutrition², they account for 52% of the total costs of malnutrition.³ With ever-tighter budgets, you can’t afford wastage.

To Better Manage Malnutrition, Complexity Must Be Minimised

Only Abbott can offer a simple product range with one unifying brand name, which can make following guidelines and product choice altogether easier.

The Ensure range covers the majority of your patients’ needs with great tasting ONS, preferred by patients and trusted by HCPs.^4-6

ENSURE COMPACT
99% compliance and minimal wastage^*5
For those who cannot consume large volumes
Suitable for most patients and may aid compliance, with the presentation preferred by most people⁺⁶
Click here for Ensure Compact product details

ENSURE PLUS ADVANCE
Only high-protein ONS that contains additional vitamin D and calcium HMB^‡§
Formulated specifically for patients aged >65 who have, or are at risk of, malnutrition
Clinically proven to reduce the risk of death by 50% in malnourished, hospitalised, older patients with cardiac or respiratory disease^|7
Click here for Ensure Plus Advance product details

ENSURE PLUS JUCE
For those who prefer juice-style drinks or those with taste fatigue
Contains more energy and protein than any other juice-style ONS^**
Click here for Ensure Plus juice product details

For further information about these 3 products, visit https://support.ensure.abbott/uk

Let Us Help You Simplify The Process Of Managing Malnutrition

To arrange a meeting with your local account manager please email ukabbottnutrition@abbott.com or call 0800 252 882.

*62% of people preferred two 125 ml servings per day vs two 200 ml or one 220 ml serving a day (n=58).

†Independent research of 25 adults who were asked to drink 2 bottles of Ensure Compact a day for 7 days. Only 3 out of 350 Ensure Compact bottles were not consumed.

‡ In the UK.

§ HMB: β-hydroxy-β-methyl butyrate.

| As shown in a randomised control trial to investigate the effects of a specialised ONS (the UK equivalent product is Ensure Plus Advance) on malnourished, cardiopulmonary patients (≥65 years) vs standard care. Ensure Plus Advance was initiated within 72 h of hospitalisation and continued for 90-days post-discharge. Ensure Plus Advance decreased the risk of mortality at 90 days post-hospital discharge vs standard post-op nutrition (4.8% vs 9.7%; p=0.018), however the study did not observe a significant effect for the primary composite endpoint of non-elective readmission or death.

** Per serving, Fresubin Jucy and Fortijuce contain 8 g protein and 300 kcal, while Altrajuce contains 7.8 g protein and 300 kcal. Fresubin Jucy and Fortijuce are therefore the next best alternatives to Ensure Plus Juce for energy and protein.

References

MIMS June 2020.
Malnutrition Task Force: State of the Nation, 2017: https://www.malnutritiontaskforce.org.uk/sites/default/files/2019-09/State%20of%20the%20Nation.pdf Accessed July 2020.
BAPEN, 2018:https://www.bapen.org.uk/pdfs/reports/mag/managing-malnutrition.pdf Accessed July 2020
Data on File. Abbott Laboratories Ltd., 2013 (GP Quant Survey on ONS).
Data on File. Abbott Laboratories Ltd., 2013 (Ensure Compact Palatability Research).
Data on File. Abbott Laboratories Ltd., 2018 (ONS Preference Data)
Deutz NE et al. Clin Nutr 2016;35(1):18-26.

July 2020 UK-ENSC-2000028